180 related articles for article (PubMed ID: 16688032)
1. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue.
Patel VV; Zhao L; Wong P; Kanim L; Bae HW; Pradhan BB; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(11):1201-6. PubMed ID: 16688032
[TBL] [Abstract][Full Text] [Related]
2. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
[TBL] [Abstract][Full Text] [Related]
3. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
4. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
5. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
[TBL] [Abstract][Full Text] [Related]
6. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
9. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
10. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.
Oluigbo CO; Solanki GA
Pediatr Neurosurg; 2008; 44(5):393-6. PubMed ID: 18703886
[TBL] [Abstract][Full Text] [Related]
13. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment.
Huang KY; Yan JJ; Hsieh CC; Chang MS; Lin RM
Spine (Phila Pa 1976); 2007 May; 32(11):1174-80. PubMed ID: 17495773
[TBL] [Abstract][Full Text] [Related]
14. ISSLS prize winner: positron emission tomography and magnetic resonance imaging for monitoring interbody fusion with equine bone protein extract, recombinant human bone morphogenetic protein-2, and autograft.
Foldager C; Bendtsen M; Zou X; Zou L; Olsen AK; Munk OL; Stødkilde-Jørgensen H; Bünger C
Spine (Phila Pa 1976); 2008 Dec; 33(25):2683-90. PubMed ID: 19002076
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2.
Jung RE; Schmoekel HG; Zwahlen R; Kokovic V; Hammerle CH; Weber FE
Clin Oral Implants Res; 2005 Dec; 16(6):676-82. PubMed ID: 16307574
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.
Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL
Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492
[TBL] [Abstract][Full Text] [Related]
17. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment.
Wikesjö UM; Sorensen RG; Kinoshita A; Jian Li X; Wozney JM
J Clin Periodontol; 2004 Aug; 31(8):662-70. PubMed ID: 15257745
[TBL] [Abstract][Full Text] [Related]
18. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2.
Rai B; Teoh SH; Hutmacher DW; Cao T; Ho KH
Biomaterials; 2005 Jun; 26(17):3739-48. PubMed ID: 15621264
[TBL] [Abstract][Full Text] [Related]
19. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
[TBL] [Abstract][Full Text] [Related]
20. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
Vaidya R; Sethi A; Bartol S; Jacobson M; Coe C; Craig JG
J Spinal Disord Tech; 2008 Dec; 21(8):557-62. PubMed ID: 19057248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
